Strong increase in PD-L1+ and IL-10+-expressing CD19+B220+CD5+CD1d+ and CD19-B220+CD5+CD1d- Bregs in murine MASLD and HCC in situ. This evidence concerns the gene CD19 and hepatocellular carcinoma.